Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genelux Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GNLX
Nasdaq
2830
www.genelux.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genelux Corporation
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with OlviāVec in Ovarian Cancer
- Jun 30th, 2026 6:00 am
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
- May 7th, 2026 2:15 pm
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
- Mar 19th, 2026 2:15 pm
Genelux Corporation to Participate in Upcoming Conferences
- Feb 18th, 2026 6:00 am
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
- Jan 12th, 2026 2:00 pm
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
- Jan 8th, 2026 7:13 am
Genelux Corporation Announces Proposed Public Offering of Common Stock
- Jan 7th, 2026 2:01 pm
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
- Jan 5th, 2026 6:00 am
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
- Jan 2nd, 2026 6:00 am
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
- Nov 26th, 2025 6:00 am
Institutions along with retail investors who hold considerable shares inGenelux Corporation (NASDAQ:GNLX) come under pressure; lose 16% of holdings value
- Nov 20th, 2025 3:35 am
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
- Nov 5th, 2025 2:20 pm
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?
- Oct 5th, 2025 7:22 am
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
- Sep 2nd, 2025 2:01 pm
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
- Aug 7th, 2025 2:20 pm
3 Promising Penny Stocks With Market Caps Under $200M
- Jul 15th, 2025 12:09 pm
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
- Jul 7th, 2025 5:00 am
Scroll